Moomoo AI 已提取核心訊息
Thomas F. Cowhey, SVP and Interim CFO of CVS Health Corp (CVS), completed a sale of 5,641 shares of common stock on February 28, 2024. The transaction was carried out at a price of $75.19 per share, resulting in a total value of $424,146.79. Following the sale, Cowhey's direct holdings in CVS Health Corp amount to 28,631 shares. The sale was executed as a means to cover the exercise price or tax liability by delivering or withholding securities, according to the transaction code description.
Thomas F. Cowhey, SVP and Interim CFO of CVS Health Corp (CVS), completed a sale of 5,641 shares of common stock on February 28, 2024. The transaction was carried out at a price of $75.19 per share, resulting in a total value of $424,146.79. Following the sale, Cowhey's direct holdings in CVS Health Corp amount to 28,631 shares. The sale was executed as a means to cover the exercise price or tax liability by delivering or withholding securities, according to the transaction code description.
CVS Health Corp（CVS）高級副總裁兼臨時首席財務官托馬斯·考威於2024年2月28日完成了5,641股普通股的出售。該交易以每股75.19美元的價格進行，總價值爲424,146.79美元。出售後，Cowhey在CVS Health Corp的直接持股量爲28,631股。根據交易代碼的描述，此次出售是通過交付或預扣證券來支付行使價或納稅義務的一種手段。
CVS Health Corp（CVS）高級副總裁兼臨時首席財務官托馬斯·考威於2024年2月28日完成了5,641股普通股的出售。該交易以每股75.19美元的價格進行，總價值爲424,146.79美元。出售後，Cowhey在CVS Health Corp的直接持股量爲28,631股。根據交易代碼的描述，此次出售是通過交付或預扣證券來支付行使價或納稅義務的一種手段。
有用
沒用